Norfolk research company plans clinical trials using medical marijuana
Eighteen months after receiving a broad federal license for importing medical cannabis, a Norfolk research company is about to embark on a series of critical studies into a variety of medical and mental disorders, diseases and conditions.
Sanyal Biotechnology is already considering proposals for research campuses and planning its first clinical trial for this summer. The new venture potentially opens the door to significantly expanding national research being done on the medical benefits of cannabis. Read the full story here.
Stories you may be interested in
European Parliament Passes Cannabis Resolution, Joins WHO In Supporting Medical Marijuana
Following reports about the World Health Organization (WHO) recommending a rescheduling of cannabis and several of its key components under international drug treaties, the European Parliament voted on Wednesday on a resolution that would help advance medical cannabis in the countries that form the European Union. Read the full story here.
Read More 
Medical Marijuana and Cancer
September is dedicated to recognizing numerous cancers that many around the world suffer from, including prostate, thyroid, ovarian and blood cancers. These cancers and many others can produce life-debilitating symptoms and conditions that are difficult to treat with traditional medications. Although there might not be one ‘perfect fix’ when it comes to curing cancer, medical…
Read More 
PTSD and Cannabis
Post-Traumatic Stress Disorder (PTSD) is a psychiatric disorder that occurs in people who witnessed or have gone through a traumatic event. That can include events such as natural disasters, war/combat, a serious accident, or personal assault, among others. People suffering from PTSD have disturbing thoughts and feelings related to the traumatic event that can last…
Read More 
Cannabis and Seniors
As more and more research comes out regarding the medical benefits of cannabis, it’s important to keep up with new research as it becomes available. Here at Arfinn Med, we constantly review new studies and look at our own deidentified efficacy data to try to find any additional insights we can relay to our registered…
Read More
DeSantis OKs telehealth for Florida medical marijuana patients
TAMPA, Fla. (WFLA) — Florida Gov. Ron DeSantis signed a bill allowing the state’s 828,000 medical marijuana patients to use telehealth to visit their doctors. On Monday, DeSantis signed HB-387, titled “Medical Use of Marijuana,” which allows patients renewing their medical marijuana recommendation to meet with their doctors online. Currently, patients must visit their doctor in person…
Read More 
New Feature Updates
It’s a new feature alert! At Arfinn Med we always work to make sure we are the industry leading software platform and EMR for medical cannabis providers and clinics. Keeping with that sentiment, we’ve recently updated two features that have been very popular with Arfinn Med users. Those are the customizable consent and confirmation page…
Read More